Newsletter | November 19, 2026

11.19.26 -- Will The FDA Finish What It Started With Real-Time CRLs?

INDUSTRY INSIGHTS

Accelerating Technology Transfer Of A Drug Product

See how structured testing can reduce transfer risk, confirm scalability and reuse strategies, as well as how to improve process robustness and deliver meaningful savings on chemicals and consumables.

FEATURED EDITORIAL

When Lyophilization Fails At Scale, First Scrutinize Your Formulation

When lyophilizing a challenging biologic drug product, use an integrated approach optimizing formulation and process parameters together.

Navigating Outsourced Pharma Testing In Today's Geopolitical Uncertainty

Geopolitical shocks are reshaping outsourced pharmaceutical testing. Learn how procurement teams can strengthen resilience and protect continuity.

Will FDA Finish What It Started: Real-Time CRLs? An Incomplete Response

FDA’s real-time CRL releases face legal and operational hurdles. Could AI-assisted redaction make transparency faster and more consistent?

SOLUTIONS

A Semi-Automated Tangential Flow Filtration System